OpenEMR is a free and open source electronic health records and medical practice management application. Prior to 8.0.0.1, an inverted boolean condition in ControllerRouter::route() causes the admin/super ACL check to be enforced only for controllers that already have their own internal authorization (review, log), while leaving all other CDR controllers — alerts, ajax, edit, add, detail, browse — accessible to any authenticated user. This allows any logged-in user to suppress clinical decision support alerts system-wide, delete or modify clinical plans, and edit rule configurations — all operations intended to require administrator privileges. This vulnerability is fixed in 8.0.0.1.
Severity
CVSS 3.1
8.1 high
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
EPSS
0.3%(unchanged from 0.3% a week ago; 0.5% 30 days ago) estimated probability of exploitation activity in the next 30 days; 24th percentile. Scored 2026-11-22. A forecast for this CVE across the internet, not for your own systems.
CISA's assessment (SSVC)
Exploitation: PoC · Automatable: no · Technical impact: partial, assessed 2026-03-12. From CISA's Vulnrichment in the CVE List: whether it is exploited, whether exploiting it can be automated, and how much control it gives.
Show the promptExplain CVE-2026-32126 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2026-32126?via=ask-ai-copy and https://cve.bz/cve/CVE-2026-32126?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2026-32126 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.
Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.